Investigation of the Activity of Antisense Oligonucleotides Targeting Multiple Genes by RNA-Sequencing

Nucleic Acid Ther. 2021 Dec;31(6):427-435. doi: 10.1089/nat.2020.0932. Epub 2021 Jul 10.

Abstract

Locked nucleic acid-modified antisense oligonucleotides (ASOs) can achieve strongly different degrees of target knockdown despite having similar biophysical properties and 100% homology with their target. The determinants for this observation remain largely unknown. We used multi-specific ASOs that have 100% sequence complementarity with a common target (IDO1) and a different number of diverse targets and investigated their effect on gene expression in a cell line by RNA-sequencing. We observed a significant higher chance for downregulation of long genes compared to short genes, of genes with high compared to lower expression, and of genes that have more than one binding site for the respective ASO. By investigating the expression of genes that have binding sites for more than one ASO we identified the individual binding site being an important determinant for activity. Under the selected experimental conditions we have not seen indications that availability of RNase H is a limiting factor as the number of degraded target RNA molecules correlated significantly with the number of predicted target RNA molecules. Taken together, by using multi-specific ASOs as tool compounds we identified determinants for ASO activity that can be taken into consideration to improve the selection process of highly potent and selective ASOs in the future.

Keywords: Antisense Oligonucleotides; Locked nucleic acid; RNA-sequencing.

MeSH terms

  • Binding Sites
  • Cell Line
  • Oligonucleotides, Antisense* / genetics
  • RNA
  • Ribonuclease H* / genetics

Substances

  • Oligonucleotides, Antisense
  • RNA
  • Ribonuclease H